Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds

MONDAY, July 11, 2022 -- Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in Pediatrics. Anne M. Hause,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news